FY2025 · period end Oct '25 · from the 10-K filed Dec 12, 2025
| Metric | FY25Oct '25 | FY24Oct '24 | FY23Oct '23 | FY22Oct '22 | FY21Oct '21 |
|---|---|---|---|---|---|
| Revenue | $1.84B | $1.28B | $1.13B | $1.22B | $1.07B |
| Gross Profit | $0.50B | $0.31B | $0.28B | $0.27B | $0.24B |
| Operating Income | negative: -$0.19B | $0.05B | $0.11B | $0.11B | $0.08B |
| Net Income | negative: -$0.25B | $0.03B | $0.08B | $0.09B | $0.06B |
| EPS (Diluted) | negative: -$5.43 | $0.90 | $2.50 | $2.66 | $1.70 |
| Metric | FY25Oct '25 | FY24Oct '24 | FY23Oct '23 | FY22Oct '22 | FY21Oct '21 |
|---|---|---|---|---|---|
| Total Assets | $1.97B | $2.32B | $0.83B | $0.72B | $0.72B |
| Total Liabilities | $1.24B | $1.31B | $0.29B | $0.26B | $0.30B |
| Stockholders' Equity | $0.73B | $1.01B | $0.55B | $0.46B | $0.42B |
| Cash & Equivalents | $0.08B | $0.10B | $0.06B | $0.06B | $0.04B |
| Total Debt | $0.67B | $0.74B | $0.07B | $0.03B | $0.05B |
| Metric | FY25Oct '25 | FY24Oct '24 | FY23Oct '23 | FY22Oct '22 | FY21Oct '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.16B | $0.09B | $0.15B | $0.10B | $0.08B |
| Capital Expenditures | $0.06B | $0.04B | $0.04B | $0.03B | $0.02B |
| Free Cash Flow | $0.10B | $0.05B | $0.11B | $0.06B | $0.05B |
| Metric | FY25Oct '25 | FY24Oct '24 | FY23Oct '23 | FY22Oct '22 | FY21Oct '21 |
|---|---|---|---|---|---|
| Gross Margin | 27.2% | 23.9% | 24.5% | 22.0% | 22.4% |
| Operating Margin | negative: -0.1% | 0.0% | 0.1% | 0.1% | 0.1% |
| Net Margin | negative: -0.1% | 0.0% | 0.1% | 0.1% | 0.1% |
| Return on Equity | negative: -28.9% | 4.2% | 16.3% | 20.0% | 14.7% |
| Return on Assets | negative: -11.7% | 2.1% | 10.6% | 12.3% | 8.1% |
| Debt / Equity | 0.92× | 0.73× | 0.12× | 0.06× | 0.12× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001423221-26-000034 | Apr 30, 2026 | Jun 5, 2026 | Jun 5, 2026 20:15 UTC | EDGAR |
| 8-K | 0001171843-26-003917 | Jun 4, 2026 | Jun 4, 2026 | Jun 4, 2026 20:17 UTC | EDGAR |
| 8-K | 0001171843-26-003761 | May 28, 2026 | May 28, 2026 | May 28, 2026 20:17 UTC | EDGAR |
| 10-Q | 0001423221-26-000017 | Jan 31, 2026 | Mar 6, 2026 | Mar 6, 2026 21:15 UTC | EDGAR |
| 8-K | 0001171843-26-001364 | Mar 5, 2026 | Mar 5, 2026 | Mar 5, 2026 21:17 UTC | EDGAR |
| 8-K | 0001104659-26-022858 | Feb 26, 2026 | Mar 3, 2026 | Mar 3, 2026 21:15 UTC | EDGAR |
| 8-K | 0001171843-26-001142 | Feb 26, 2026 | Feb 26, 2026 | Feb 26, 2026 21:17 UTC | EDGAR |
| 8-K | 0001104659-26-004552 | Jan 13, 2026 | Jan 16, 2026 | Jan 16, 2026 21:15 UTC | EDGAR |
Direct links to SEC EDGAR. NX has additional filings available on the SEC site.
6 numbers Quanex Building Products CORP later changed — same XBRL tag, both filings linked.
Operating Income (Loss)·Q1 2014
Major restatementwas-$5.1M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q1 2014
Major restatementwas-$5.2M
Revised up in a 10-Q.
Operating Income (Loss)·FY 2012
Major restatementwas-$25M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2012
Major restatementwas-$25.2M
Revised up in a 10-K.
Revenues·FY 2012
Major restatementwas$829M
Revised down in a 10-K. Any P/S built on the original was 73.2% too low.
Revenues·FY 2013
Major restatementwas$952.6M
Revised down in a 10-K. Any P/S built on the original was 71.7% too low.
NX is not the only one.
See every restatement we've found across the market — or get an alert the next time NX revises a number.
Restatements are detected by comparing every vintage of a fact across all of Quanex Building Products CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows NX's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Quanex Building Products CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on NX yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on NX and publish the result to your public profile.
Ask about Quanex Building Products CORP
Continue in Workspace — cited answers on NX, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs